Davis Capital Management

Position in ABBV — AbbVie Inc.

CIK 1811806 JACKSONVILLE, FL

Position in ABBV

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$1,334,195

+$175,844 QoQ

Shares Held

5,302

-0.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.41%

of 13F equity value

Holder Rank

#2,285

of 4,153 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Davis Capital Management holds $6,297,182 across 10 Drug Manufacturers - General names. ABBV ranks #3 (21.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	9,856	$2,503,128
2	AMGN	Amgen Inc	6,521	$2,361,384
3	ABBV	AbbVie Inc. This page	5,302	$1,334,195
4	LLY	ELI LILLY & Co	61	$73,165
5	GILD	Gilead Sciences, Inc.	80	$10,107
6	MRK	Merck & Co., Inc.	58	$7,453
7	BMY	Bristol Myers Squibb Co	59	$3,399
8	PFE	Pfizer Inc	137	$3,298

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,334,195	5,302	-0.5%	Shares	Sole	2026-07-16
2026-03-31	$1,158,351	5,326	-0.4%	Shares	Sole	2026-04-16
2025-12-31	$1,221,964	5,348	-0.5%	Shares	Sole	2026-01-28
2025-09-30	$1,244,759	5,376	-0.1%	Shares	Sole	2025-10-21
2025-03-31	$1,127,636	5,382	-2.0%	Shares	Sole	2025-04-11
2024-12-31	$975,750	5,491	-2.1%	Shares	Sole	2025-01-17
2024-09-30	$1,107,862	5,610	-1.3%	Shares	Sole	2024-10-01
2024-06-30	$975,091	5,685	-0.7%	Shares	Sole	2024-07-02
2024-03-31	$1,042,704	5,726	-1.5%	Shares	Sole	2024-04-05
2023-12-31	$900,995	5,814	-18.7%	Shares	Sole	2024-02-14
2020-06-30	$702,477	7,155	-2.1%	Shares	Sole	2020-07-29
2020-03-31	$556,720	7,307	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.